MedPath

Patient Performed Examination for Patients With Intra-articular Hip Pain

Not Applicable
Completed
Conditions
Hip Pain Chronic
Hip Disease
Interventions
Other: Clinician-Performed Diagnostic Exam
Other: Patient Self-Administered Diagnostic Exam
Registration Number
NCT03248934
Lead Sponsor
Duke University
Brief Summary

The primary objective of this study is evaluate the diagnostic accuracy of a patient self-administered clinical examination of the hip compared with a traditional clinical examination (i.e. index test).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Age: 18-80 years
  • Seeking care for hip related pain and/or clicking, catching, giving way or stiffness
  • Able to sign or verbalize study consent
  • No other medical conditions (e.g. gynecological or urinary pathology) that may affect study results
  • English speaking
Read More
Exclusion Criteria
  • Patients with primary lumbar spine, sacro-iliac or other non-hip related pain as determined with clinical examination
  • Previous hip surgery
  • Previous hip injury that would normally exclude from examination as standard practice
  • Unable to sign or verbalize consent
  • Other non-musculoskeletal pathology that may affect study results (e.g. gynecological or urinary pathology)
  • Non-English speaking
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Clinician-Performed Exam GroupClinician-Performed Diagnostic ExamParticipants with hip pain presenting in the hip preservation clinics will be asked to complete two diagnostic exams. Participants with hip pain will next complete a clinician-performed diagnostic exam.
Patient Self-Administered Exam GroupPatient Self-Administered Diagnostic ExamParticipants with hip pain presenting in the hip preservation clinics will be asked to complete two diagnostic exams. Participants with hip pain will first complete a patient self-administered diagnostic exam.
Primary Outcome Measures
NameTimeMethod
SensitivityEnd of clinician examination, 20 minutes

As measured by a questionnaire evaluating the diagnostic test's ability to identify a positive finding when the targeted diagnosis is actually present (i.e. true positive).

Secondary Outcome Measures
NameTimeMethod
SpecificityEnd of clinician examination, 20 minutes

As measured by the discriminatory ability of the diagnostic test to identify if the disease or condition is absent when in actuality it is truly absent (i.e. true negative).

Diagnostic accuracy measure of negative likelihood ratioEnd of clinician examination, 20 minutes

As measured by sensitivity and specificity values.

Diagnostic accuracy measure of post-test probabilitiesEnd of clinician examination, 20 minutes

As measured by analysis of the pre-test prevalence of the condition and determination of the post-test shift in probability of the condition.

Diagnostic accuracy measure of positive likelihood ratioEnd of clinician examination, 20 minutes

As measured by sensitivity and specificity values.

Trial Locations

Locations (1)

Duke University Health System

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath